|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Earnings attributable to common shareholders | |||||
| Adjustments for items not involving cash: | |||||
| Share of profit from equity accounted investees (Note 10) | |||||
| Depreciation and amortization | |||||
| Impairment reversal (Note 9) | |||||
| Unrealized loss (gain) on commodity-related derivative financial instruments (Note 23) | |||||
| Loss on acquisition | |||||
| Unrealized loss from derivative instruments (Note 23) | |||||
| Net finance costs (Note 19) | |||||
| Share-based compensation expense (Note 21) | |||||
| Income tax expense (recovery) (Note 11) | |||||
| Gain on asset disposal | |||||
| Derecognition of insurance contract provision | |||||
| Cash items paid or received: | |||||
| Distributions from equity accounted investees (Note 10) | |||||
| Net interest paid (Note 19) | |||||
| Share-based compensation payment | |||||
| Taxes paid | |||||
| Change in non-cash operating working capital | |||||
| Net change in contract liabilities (Note 18) | |||||
| Other | |||||
| Cash flow from operating activities | |||||
| Financing activities | |||||
| Net increase (decrease) in bank borrowings (Note 14) | |||||
| Proceeds from issuance of long-term debt, net of issue costs (Note 14) | |||||
| Proceeds from subscription receipts (Note 16) | |||||
| Repayment of long-term debt | |||||
| Repayment of lease liability | |||||
| Issuance of common shares on exercise of options | |||||
| Repurchase of common shares (Note 17) | |||||
| Redemption of preferred shares (Note 16) | |||||
| Dividends paid | |||||
| Common share capital | |||||
| Preferred share capital | |||||
| Distributions to non-controlling interest | |||||
| Purchase of non-controlling interest | |||||
| Cash flow (used in) from financing activities | |||||
| Investing activities | |||||
| Capital expenditures | |||||
| Contributions to equity accounted investees (Note 10) | |||||
| Net proceeds from disposition | |||||
| Acquisition | |||||
| Proceeds from sale of assets | |||||
| Receipt of finance lease payments | |||||
| Interest paid during construction (Note 19) | |||||
| Long-term loan receivable on asset | |||||
| Advances to related parties (Note 26) | |||||
| Return of capital from equity accounted investees (Note 10) | |||||
| Changes in non-cash investing working capital and other | |||||
| Cash flow used in investing activities | |||||
| Change in cash and cash equivalents | |||||
| Effect of movement in exchange rates on cash held | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Long-term restricted cash included in other assets | |||||
| Short-term cash and cash equivalents, end of period | |||||
Loading...
